$ABCB

Ameris Bancorp

3
2
3

No SEC Form 4 filings for $ABCB in the last 30 days.

See all $ABCB insider activity →
High

Ameris Q3 2026 slides: earnings hit 5-year high, efficiency improves

Ameris Bancorp (ABCB) reported Q3 2026 earnings of $1.73 per share, beating estimates, with revenue at $321.85M, slightly below forecasts. Net income was $116.1M, up from prior periods, with improved efficiency. Loan and deposit growth were steady, and the stock price rose 0.56% to $82.83.

AMERIS BANCORP ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

Ameris Bancorp (ABCB) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release AMERIS BANCORP ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS Highlights of Ameris’s results for the third quarter of 2026 include the following: • Net income of $116.1 million, or $1.73 per diluted share • Return on average assets of 1.61% • Return on average tangib

ABCB sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 8 news stories mentioning ABCB (Ameris Bancorp). Coverage has been balanced: 3 bullish, 2 neutral, and 3 bearish.

Recent ABCB coverage spans earnings, financial news and corporate actions.

What's driving ABCB

  • Earnings beat and operational improvements suggest near‑term upside.

    investing.com · Oct 23, 2026

  • Earnings beat and margin expansion suggest modest upside pressure.

    SEC EDGAR 8-K · Oct 22, 2026

  • Ameris Bancorp's board authorized a stock buyback program of up to $200M. Q3 2026 results: net income $116.1M, EPS $1.73, ROA 1.61%, ROE 15.01%. Loan/deposit growth and tangible book value per share increased. CEO highlights profitable growth and expense discipline. Conference call scheduled for Oct 23, 2026.

    stocktitan.net · Oct 22, 2026

  • Pre-earnings preview suggests potential downside pressure if results miss expectations.

    finance.yahoo.com · Oct 21, 2026

  • Small insider purchase adds modest buying pressure but unlikely to move the stock materially.

    stocktitan.net · Sep 16, 2026

AlphAI scores every news story that mentions ABCB with an AI model for sentiment and relevance, and aggregates insider trades from Ameris Bancorp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ABCB

Score
$ABCBMed

AMERIS BANCORP ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS

Ameris Bancorp (ABCB) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release AMERIS BANCORP ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS Highlights of Ameris’s results for the third quarter of 2026 include the following: • Net income of $116.1 million, or $1.73 per diluted share • Return on average assets of 1.61% • Return on average tangib

What To Expect From Ameris Bancorp’s (ABCB) Q3 Earnings

Ameris Bancorp (ABCB) will report Q3 earnings Thursday. Last quarter, it missed revenue expectations with $318.7M (up 5.8% YoY) and EPS estimates. Analysts expect 4% YoY revenue growth this quarter. ABCB's peers showed mixed results, with Washington Trust Bancorp beating estimates and QCR Holdings missing. ABCB's stock is down 2.8% in the last month, with an average price target of $93.17.

Ameris Bancorp: Q2 Earnings Snapshot

Ameris Bancorp (ABCB) reported Q2 net income of $51.4 million, or 77 cents per share. Adjusted earnings were $1.60 per share, below Zacks’ consensus of $1.66. Revenue was $439.1 million, with revenue net of interest expense at $334.4 million versus $322.2 million expected. Shares rose to $89.16 on Thursday.

$ABCBMed

AMERIS BANCORP ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS

Ameris Bancorp (ABCB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991pressreleasedate.htm EX-99.1 Document News Release AMERIS BANCORP ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Highlights of Ameris’s results for the second quarter of 2026 include the following: • Net income of $51.4 million, or $0.77 per diluted share • A

Ameris Bancorp Earnings: What To Look For From ABCB

Ameris Bancorp (NYSE: ABCB) is set to report earnings Thursday. The prior quarter showed $315.3M revenue, up 10% year over year, with a narrow net interest income beat but a slight tangible book value per share miss. Analysts expect revenue growth of 7.3% YoY. The article cites an average analyst price target of $95.17 versus $90.60.

$AXPMed

American Express, Biogen upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes. JPMorgan raised American Express (AXP) to Overweight, PT $400. Truist upgraded Biogen (BIIB) to Buy, PT $235, citing upcoming Phase 2 and Phase 3 readouts. JPMorgan also raised Keysight (KEYS) to Overweight, PT $400. Other actions included upgrades for Humana (HUM) and downgrades for Papa John’s (PZZA) and Best Buy (BBY).

Related tickers